• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

GPBCH Issues Action Brief on Obesity Drug Coverage

Article

The Greater Philadephia Business Coalition on Health (GPBCH) issued a member action brief on "Covering Prescription Weight Loss Therapies to Address Obesity," which reviews the available evidence on effectiveness and safety (including side effects) of the new generation of obesity drugs and recommends that employers consider covering these drugs in concert with lifestyle change programs.

On March 7, the Greater Philadephia Business Coalition on Health (GPBCH) issued a member action brief on "Covering Prescription Weight Loss Therapies to Address Obesity." The brief reviews the available evidence on effectiveness and safety (including side effects) of the new generation of obesity drugs and recommends that employers consider covering these drugs in concert with lifestyle change programs.

Content for the Action Brief was gathered by Ileka Ifejika, a third year student in the Jefferson College of Pharmacy, doing an internship with GPBCH; a draft was reviewed by the GPBCH Employee Health and Well-being Interest Group, and 2 weight management clinicians.

Read the full brief.

Related Videos
Merrill H. Stewart, MD
Dr John Mascarenhas
Dr Sundar Jagannath
Hamlet Gasoyan, PhD
Eric Lander, MD
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.